A Connecticut-headquartered biopharmaceutical company and a Connecticut hospital are key participants in what is potentially the most comprehensive and promising research effort into finding an effective treatment for amyotrophic lateral sclerosis (ALS) - known as Lou Gehrig’s Disease - which has stubbornly eluded researchers.
Read MoreConnecticut’s success-to-date in knocking down the spread of the coronavirus can be attributed to many decisions made by the state’s leaders and individual residents across the state. Among those efforts which have received less attention, but contributed to the progress, is a special committee of experts quickly set up by the Connecticut Academy of Science and Engineering (CASE).
Read MoreSikorsky, a Lockheed Martin Company, is the 2020 recipient of the Connecticut Medal of Technology in recognition of X2 Technology, a generational leap in rotary wing innovation that enables helicopters to complete tasks traditional helicopters can’t today. Matt Fleury, CEO of the Connecticut Science Center, is selected as an Honorary Member of the Connecticut Academy of Science and Engineering, and 36 new members of the Academy are elected.
Read MoreHow children are fed may be just as important as what they are fed, according to a new scientific statement from the American Heart Association. The formal statement is the first ever from the Association focused on providing evidence-based strategies for parents and caregivers to create a healthy food environment for young children, and very much in line with ongoing research by the Rudd Center at UConn.
Read MoreHaving a specific gene, which previous genetic studies have found to be linked to dementia, doubles the risk of developing severe COVID-19, according to a newly published large-scale study with data analysis led by a University of Connecticut researcher.
Read MoreThe findings of a COVID-19 Community Survey Report conducted by the National Organization for Rare Disorders (NORD) reveals the far-reaching impact the pandemic is having on patients and families with rare disorders.
Read MoreReopening Connecticut and getting the state back on its economic feed is taking a village of local volunteers. The newest initiative, to include municipal officials, community-based organizations, nonprofit providers, and philanthropic partners – establishes local long-term recovery committees that will help meet urgent needs, accelerate recovery, and expedite coordination with the state’s emergency management structure,
Read MoreJust as the United States was recognizing the severity of the coronavirus and state governments were reacting to the impending health crisis, a Farmington-based company with ties to the University of Connecticut that has been pursuing a cure for another elusive disease received milestone news from the U.S. Food and Drug Administration (FDA).
Read MoreA University of Connecticut researcher has launched a year-long study to examine how behavior and social attitudes change, and what factors influence those changes, when people in the United States are faced with the threat of widespread disease. A National Science Foundation grant will fund the national study, which is already underway.
Read MorePerkin-Elmer, a global company with Connecticut faciities in Branford and Shelton, has announced that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for the company’s New Coronavirus RT-PCR test.
Read More
© 2025 Connecticut By The Numbers [TM]
430 New Park Avenue, Suite 102, West Hartford, CT 06110
Designed by RDK Design & Photography
